Don't miss

Replay


LATEST SHOWS

THE DEBATE

Trump at NATO: What future for the Atlantic Alliance? (part 2)

Read more

THE DEBATE

Trump at NATO: What future for the Atlantic Alliance? (part 1)

Read more

FOCUS

Life after IS group: Young Iraqis learn to live together in Kirkuk

Read more

ENCORE!

Cannes 2017: Robert Pattinson stars in Safdie brothers heist 'Good Time'

Read more

THE INTERVIEW

Trump on 'learning curve' but poll numbers 'will go up'

Read more

INSIDE THE AMERICAS

Is Venezuela on the verge of anarchy?

Read more

IN THE PAPERS

Donald Trump meets Emmanuel Macron: Can they get on?

Read more

IN THE PAPERS

Manchester bomber 'fits profile of other terrorists'

Read more

BUSINESS DAILY

OPEC looks set to extend production cut

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)